Gasotransmitter-Induced Therapeutic Angiogenesis: A Biomaterial Prospective.

Abstract

Gasotransmitters such as NO, H2S, and CO have emerged as key players in the regulation of various pathophysiological functions, prompting the development of gas therapy for various pathogeneses. Deficient production of gasotransmitters has been linked to various diseases such as hypertension, endothelial dysfunction, myocardial infarction, ischemia, and impaired wound healing, as they are involved in the regulatory action of angiogenesis. A better understanding of the regulatory mechanisms has given new hope to address the vascular impairment caused by the breakthroughs in gasotransmitters as therapeutics. However, the unstable nature and poor target specificity of gas donors limit the full efficacy of drugs. In this regard, biomaterials that possess excellent biocompatibility and porosity are ideal drug carriers to deliver the gas transmitters in a tunable manner for therapeutic angiogenesis. This review article provides a comprehensive discussion of biomaterial-based gasotransmitter delivery approaches for therapeutic angiogenesis. The critical role of gasotransmitters in modulating angiogenesis during tissue repair as well as their challenges and future directions are demonstrated.

• Authors: Becky Robert, Sadhasivam Subramaniam
• Journal: ACS omega (ACS Omega) Vol. 7 Issue 50 Pg. 45849-45866 (Dec 20 2022) ISSN: 2470-1343 [Electronic] United States
• PMID: 36570231 (Publication Type: Journal Article, Review)
• Copyright: © 2022 The Authors. Published by American Chemical Society.